Clinical Trial

From Benchmark to Surgical Activity: the Role of Endobronchial Fiducial Markers for Ground Glass Lung Nodules Resection.

Study acronym: Vortex_US
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 30, 2024 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
With the risen popularity of low-dose computed tomography (LDCT) for lung cancer screening, many patients present with peripheral pulmonary ground-glass nodules (GGNs) with a suspicious solid part. The appropriate diagnostic and management strategy for those lesions can be questionable. If malignancy is suspected, a surgical biopsy with the guidance of various localization methods available is recommended. Each localization method has its advantages and disadvantages. Therefore, it may not be possible to establish a gold standard for localizing indeterminate lung nodules since comparative clinical trials are lacking.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT05801406
Lead Sponsor IRCCS Azienda Ospedaliero-Universitaria di Bologna
Conditions Lung Cancer, Lung Non-Small Cell Carcinoma, Lung; Node
Enrollment 5 participants
Start Date 2024-10-01
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2024-07-30